Andersons pediatric cardiology 1888
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.9 KB, 3 trang )
313.OnoM,Kasnar-SamprecJ,HagerA,etal.
Clinicaloutcomefollowingtotalcavopulmonary
connection:a20-yearsingle-centreexperience.
EurJCardiothoracSurg.2016;50(4):632–641.
314.NakanoT,KadoH,TatewakiH,etal.Resultsof
extracardiacconduittotalcavopulmonary
connectionin500patients.EurJCardiothorac
Surg.2015;48(6):825–832[discussion832].
315.TweddellJS,NersesianM,MussattoKA,etal.
Fontanpalliationinthemodernera:factors
impactingmortalityandmorbidity.AnnThorac
Surg.2009;88(4):1291–1299.
316.HirschJC,GoldbergC,BoveEL,etal.Fontan
operationinthecurrentera:a15-yearsingle
institutionexperience.AnnSurg.
2008;248(3):402–410.
317.SurgeonsSoT.
/>2017.
318.NewburgerJW,SleeperLA,GaynorJW,etal.
Transplant-freesurvivalandinterventionsat6
yearsintheSVRtrial.Circulation.
2018;137(21):2246–2253.
319.DennisM,ZanninoD,duPlessisK,etal.
Clinicaloutcomesinadolescentsandadultsafter
theFontanprocedure.JAmCollCardiol.
2018;71(9):1009–1017.
320.KreutzerJ,KreutzerC.Lymphodynamicsin
congenitalheartdisease:theforgotten
circulation.JAmCollCardiol.
2017;69(19):2423–2427.
321.ItkinMG,McCormackFX,DoriY.Diagnosis
andtreatmentoflymphaticplasticbronchitisin
adultsusingadvancedlymphaticimagingand
percutaneousembolization.AnnAmThoracSoc.
2016;13(10):1689–1696.
322.DoriY,KellerMS,RomeJJ,etal.Percutaneous
lymphaticembolizationofabnormalpulmonary
lymphaticflowastreatmentofplasticbronchitis
inpatientswithcongenitalheartdisease.
Circulation.2016;133(12):1160–1170.
323.HraskaV.Decompressionofthoracicduct:new
approachforthetreatmentoffailingFontan.Ann
ThoracSurg.2013;96(2):709–711.
324.AuerbachSR,SmithJK,GrallaJ,etal.Graft
survivalisbetterwithoutpriorsurgeryincardiac
transplantationforfunctionallyuniventricular
hearts.JHeartLungTransplant.
2012;31(9):987–995.
325.KennyLA,DeRitaF,NassarM,etal.
Transplantationinthesingleventricle
population.AnnCardiothoracSurg.
2018;7(1):152–159.
326.ChokshiA,CheemaFH,SchaefleKJ,etal.
Hepaticdysfunctionandsurvivalafter
orthotopichearttransplantation:applicationof
theMELDscoringsystemforoutcome
prediction.JHeartLungTransplant.
2012;31(6):591–600.
327.KavaranaMN,SavageA,O'ConnellR,etal.
Compositeriskfactorspredictsurvivalafter
transplantationforcongenitalheartdisease.J
ThoracCardiovascSurg.2013;146(4):888–893.
328.MitchellMB,CampbellDN,IvyD,etal.
Evidenceofpulmonaryvasculardiseaseafter
hearttransplantationforFontancirculation
failure.JThoracCardiovascSurg.
2004;128(5):693–702.
329.SimpsonKE,PruittE,KirklinJK,etal.Fontan
patientsurvivalafterpediatricheart
transplantationhasimprovedinthecurrentera.
AnnThoracSurg.2017;103(4):1315–1320.
330.TabarsiN,GuanM,SimmondsJ,etal.Metaanalysisoftheeffectivenessofheart
transplantationinpatientswithafailingFontan.
AmJCardiol.2017;119(8):1269–1274.
331.KanterKR.Hearttransplantationinchildren
afteraFontanprocedure:betterthanpeople
think.SeminThoracCardiovascSurgPediatr
CardSurgAnnu.2016;19(1):44–49.
332.LuoS,HonjoO.LatedeathsafterFontan
